Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use
Nicoleta Mirela Blebea, Andreea Pricopie, Robert-Alexandru Vlad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4204-4204
Open Access | Times Cited: 17
The Origin and Biomedical Relevance of Cannabigerol
Anna Jastrząb, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7929-7929
Open Access | Times Cited: 57
A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management
Shampa Ghosh, Jitendra Kumar Sinha, Soumya K. Ghosh, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1305-1305
Open Access | Times Cited: 35
The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
Kelly A. Sagar, Staci A. Gruber
CNS Drugs (2025)
Closed Access | Times Cited: 1
Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
Brooks Johnson, Natalie Strand, John Raynak, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 530-530
Open Access | Times Cited: 1
In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
E. Pérez, José R. Fernández, Corey Fitzgerald, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 491-491
Open Access | Times Cited: 37
Cannabis sativa Cannabinoids as Functional Ingredients in Snack Foods—Historical and Developmental Aspects
Marlize Krüger, Tertia van Eeden, Daniso Beswa
Plants (2022) Vol. 11, Iss. 23, pp. 3330-3330
Open Access | Times Cited: 34
Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents
Anil Kumar Kalvala, Arvind Bagde, Peggy Arthur, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108693-108693
Open Access | Times Cited: 33
Phytocannabinoids in the Pharmacotherapy of Psoriasis
Adam Wroński, Iwona Jarocka-Karpowicz, Anna Stasiewicz, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1192-1192
Open Access | Times Cited: 19
The Skin and Natural Cannabinoids–Topical and Transdermal Applications
Silviu-Iulian Filipiuc, Anca-Narcisa Neagu, Cristina Mariana Urîtu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1049-1049
Open Access | Times Cited: 19
Hemp and Its Derivatives as a Universal Industrial Raw Material (with Particular Emphasis on the Polymer Industry)—A Review
Karol Tutek, Anna Masek
Materials (2022) Vol. 15, Iss. 7, pp. 2565-2565
Open Access | Times Cited: 24
Comparison on the mechanism and potency of hepatotoxicity among hemp extract and its four major constituent cannabinoids
Xiugong Gao, Kayla Campasino, Miranda R. Yourick, et al.
Toxicology (2024) Vol. 506, pp. 153885-153885
Open Access | Times Cited: 5
Design and Computational Study of Sulfonamide-Modified Cannabinoids as Selective COX-2 Inhibitors Using Semiempirical Quantum Mechanical Methods: Drug-like Properties and Binding Affinity Insights
Watcharin Kumaeum, Panichakorn Jaiyong
ACS Omega (2025)
Open Access
A Cross-Sectional Study on Youth and Over-the-Counter CBD Products: Understanding the Current Landscape in Spain
Alba González‐Roz, Roberto Secades‐Villa, Layla Alemán-Moussa, et al.
International Journal of Mental Health and Addiction (2025)
Open Access
Structure and Dynamics of Cannabinoid Binding to the GABAA Receptor
Lautaro D. Álvarez, N. R. Carina Alves
Proteins Structure Function and Bioinformatics (2025)
Closed Access
Bioactive Molecules from Plants: Discovery and Pharmaceutical Applications
Maria Camilla Bergonzi, Charles M. Heard, Javier García‐Pardo
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2116-2116
Open Access | Times Cited: 16
Cannabis and Cannabinoid Signaling: Research Gaps and Opportunities
Rita J. Valentino, Nora D. Volkow
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 154-158
Open Access | Times Cited: 3
Cannabinol modulates the endocannabinoid system and shows TRPV1‐mediated anti‐inflammatory properties in human keratinocytes
Camilla Di Meo, Daniel Tortolani, Sara Standoli, et al.
BioFactors (2024)
Open Access | Times Cited: 3
The Determination of Cannabinoids in Urine Samples Using Microextraction by Packed Sorbent and Gas Chromatography-Mass Spectrometry
Luana M. Rosendo, Tiago Rosado, Patrik Oliveira, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5503-5503
Open Access | Times Cited: 15
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence
Riccardo Bortoletto, Matteo Balestrieri, Sagnik Bhattacharyya, et al.
Brain Sciences (2022) Vol. 12, Iss. 1, pp. 101-101
Open Access | Times Cited: 13
Evaluation of the Analgesic Effect of High-Cannabidiol-Content Cannabis Extracts in Different Pain Models by Using Polymeric Micelles as Vehicles
Yoreny Román-Vargas, Julián David Porras-Arguello, Lucas Blandón‐Naranjo, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4299-4299
Open Access | Times Cited: 7
Should oncologists trust cannabinoids?
Ioana Creangă-Murariu, Leontina Elena Filipiuc, Magdalena Cuciureanu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Structural Basis for Molecular Recognition of Cannabinoids by Inhibitory Cys-Loop Channels
Lautaro D. Álvarez, N. R. Carina Alves
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3274-3286
Closed Access | Times Cited: 2
Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform
David A. Bunsick, Jenna Matsukubo, Myron R. Szewczuk
Cancers (2023) Vol. 15, Iss. 4, pp. 1030-1030
Open Access | Times Cited: 6
Health benefits, pharmacological properties, and metabolism of cannabinol: A comprehensive review
Aya Khouchlaa, Sara Khouri, Ahmed Hajib, et al.
Industrial Crops and Products (2024) Vol. 213, pp. 118359-118359
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top